Perspectives on the role of CD8+ cell suppressor factors and cytotoxic T lymphocytes during HIV infection
- PMID: 9672233
Perspectives on the role of CD8+ cell suppressor factors and cytotoxic T lymphocytes during HIV infection
Abstract
It is clear that HIV burden drives CD8+ cell expansion and activation in vivo, but it has been difficult to determine whether the CD8+ cell response represents a significant anti-HIV force during the natural history of infection. This issue is illustrated by the fact that CD8+ cells cannot clear HIV infection, providing less than satisfactory evidence that CD8+ cells have any substantial effect on viral replication in vivo. The diligent efforts of a number of laboratories, however, are revealing the magnitude of the anti-HIV CD8+ cell arsenal. It is now well established that CD8+ cells can suppress viral dissemination and rates of HIV transcription in addition to their ability to destroy virus-infected cells directly. This is achieved through production of a growing family of HIV suppressor factors. These exciting developments are paving the way for new studies to readdress and potentially redefine the role of HIV-specific CD8+ cell responses during HIV infection. As we complete our understanding of how these effector activities work in concert to oppose HIV, the potential that CD8+ cell responses can be manipulated by vaccination or used in conjunction with HAART holds promise in the ongoing effort to eradicate HIV infection in chronically infected individuals.
Similar articles
-
Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.J Virol. 2007 Sep;81(18):9693-706. doi: 10.1128/JVI.00492-07. Epub 2007 Jul 3. J Virol. 2007. PMID: 17609262 Free PMC article. Clinical Trial.
-
CD8 lymphocytes in HIV infection: helpful and harmful.J Clin Lab Immunol. 1997;49(1):15-32. J Clin Lab Immunol. 1997. PMID: 9819670 Review.
-
CD8+ T cell suppressor factors and the control of infection, replication and transcription of human immunodeficiency virus.Arch Immunol Ther Exp (Warsz). 2001;49(1):13-8. Arch Immunol Ther Exp (Warsz). 2001. PMID: 11266085 Review.
-
Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.Eur J Immunol. 2008 Jun;38(6):1548-58. doi: 10.1002/eji.200738054. Eur J Immunol. 2008. PMID: 18421792
-
CD8+ cell-derived anti-human immunodeficiency virus inhibitory factor.J Infect Dis. 1999 May;179 Suppl 3:S485-8. doi: 10.1086/314808. J Infect Dis. 1999. PMID: 10099125 Review.
Cited by
-
HIV-1 and the hijacking of dendritic cells: a tug of war.Springer Semin Immunopathol. 2005 Jan;26(3):309-28. doi: 10.1007/s00281-004-0178-y. Springer Semin Immunopathol. 2005. PMID: 15609004 Review.
-
A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation.J Virol. 2002 Jan;76(2):569-81. doi: 10.1128/jvi.76.2.569-581.2002. J Virol. 2002. PMID: 11752148 Free PMC article.
-
Enhancing of anti-viral activity against HIV-1 by stimulation of CD8+ T cells with thymic peptides.Clin Exp Immunol. 1999 Jul;117(1):76-83. doi: 10.1046/j.1365-2249.1999.00936.x. Clin Exp Immunol. 1999. PMID: 10403919 Free PMC article.
-
Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication.Psychosom Med. 2010 Nov;72(9):925-32. doi: 10.1097/PSY.0b013e3181f883ce. Epub 2010 Oct 14. Psychosom Med. 2010. PMID: 20947783 Free PMC article.
-
Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine.J Virol. 2000 Feb;74(4):1694-703. doi: 10.1128/jvi.74.4.1694-1703.2000. J Virol. 2000. PMID: 10644339 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical
Research Materials